Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
9.47
+0.08 (0.85%)
At close: Apr 2, 2025, 4:00 PM
9.82
+0.35 (3.74%)
After-hours: Apr 2, 2025, 5:09 PM EDT
Assembly Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 38.34 | 19.84 | 52.42 | 45.63 | 59.44 | Upgrade
|
Short-Term Investments | 73.74 | 110.41 | 39.19 | 101 | 156.97 | Upgrade
|
Cash & Short-Term Investments | 112.08 | 130.25 | 91.61 | 146.63 | 216.41 | Upgrade
|
Cash Growth | -13.95% | 42.18% | -37.52% | -32.25% | -21.03% | Upgrade
|
Accounts Receivable | - | 0.04 | 0.94 | 0.34 | 1.23 | Upgrade
|
Other Receivables | 0.4 | 0.3 | 0.3 | - | - | Upgrade
|
Receivables | 0.4 | 0.34 | 1.24 | 0.34 | 1.23 | Upgrade
|
Prepaid Expenses | 3.02 | 3.2 | 4.11 | 7.24 | 6.85 | Upgrade
|
Total Current Assets | 115.5 | 133.79 | 96.97 | 154.2 | 224.49 | Upgrade
|
Property, Plant & Equipment | 3.35 | 2.72 | 3.94 | 7.18 | 10.73 | Upgrade
|
Long-Term Investments | - | - | - | 27.97 | - | Upgrade
|
Goodwill | - | - | - | - | 12.64 | Upgrade
|
Other Intangible Assets | - | - | - | - | 29 | Upgrade
|
Long-Term Deferred Charges | - | - | 0.2 | 0.2 | 0.8 | Upgrade
|
Other Long-Term Assets | 0.31 | 0.31 | 0.69 | 1.5 | 5.59 | Upgrade
|
Total Assets | 119.17 | 136.82 | 101.79 | 191.06 | 283.25 | Upgrade
|
Accounts Payable | 0.59 | 0.46 | 2.49 | 2.66 | 4.6 | Upgrade
|
Accrued Expenses | 9.14 | 6.63 | 9.84 | 10.26 | 12.27 | Upgrade
|
Current Portion of Leases | 0.46 | 1.22 | 3.36 | 3.15 | 3.4 | Upgrade
|
Current Unearned Revenue | 37.62 | 30.92 | - | - | - | Upgrade
|
Other Current Liabilities | - | - | 0.6 | - | 4.16 | Upgrade
|
Total Current Liabilities | 47.8 | 39.23 | 16.3 | 16.07 | 24.43 | Upgrade
|
Long-Term Leases | 2.63 | 1.12 | 0.1 | 3.33 | 6.73 | Upgrade
|
Long-Term Unearned Revenue | 35.38 | 55.38 | 2.73 | 2.73 | 8.99 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 2.53 | Upgrade
|
Total Liabilities | 85.81 | 95.73 | 19.13 | 22.13 | 42.68 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0 | 0.05 | 0.03 | Upgrade
|
Additional Paid-In Capital | 859.49 | 826.92 | 807.98 | 800.73 | 742.39 | Upgrade
|
Retained Earnings | -825.93 | -785.75 | -724.52 | -631.43 | -501.57 | Upgrade
|
Comprehensive Income & Other | -0.21 | -0.08 | -0.8 | -0.42 | -0.27 | Upgrade
|
Shareholders' Equity | 33.36 | 41.1 | 82.66 | 168.93 | 240.58 | Upgrade
|
Total Liabilities & Equity | 119.17 | 136.82 | 101.79 | 191.06 | 283.25 | Upgrade
|
Total Debt | 3.09 | 2.34 | 3.47 | 6.48 | 10.13 | Upgrade
|
Net Cash (Debt) | 108.99 | 127.91 | 88.15 | 168.12 | 206.28 | Upgrade
|
Net Cash Growth | -14.79% | 45.11% | -47.57% | -18.50% | -21.20% | Upgrade
|
Net Cash Per Share | 18.15 | 27.94 | 21.85 | 46.61 | 69.87 | Upgrade
|
Filing Date Shares Outstanding | 7.5 | 5.48 | 4.33 | 4.01 | 3.19 | Upgrade
|
Total Common Shares Outstanding | 7.46 | 5.48 | 4.07 | 4.01 | 2.84 | Upgrade
|
Working Capital | 67.7 | 94.56 | 80.67 | 138.13 | 200.06 | Upgrade
|
Book Value Per Share | 4.47 | 7.50 | 20.29 | 42.13 | 84.84 | Upgrade
|
Tangible Book Value | 33.36 | 41.1 | 82.66 | 168.93 | 198.94 | Upgrade
|
Tangible Book Value Per Share | 4.47 | 7.50 | 20.29 | 42.13 | 70.16 | Upgrade
|
Machinery | - | - | 0.8 | 0.72 | 0.95 | Upgrade
|
Leasehold Improvements | - | - | 1.63 | 1.63 | 2.49 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.